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Abstract: Australian bat lyssavirus (ABLV) is a known causative agent of neurological disease in
bats, humans and horses. It has been isolated from four species of pteropid bats and a single
microbat species (Saccolaimus flaviventris). To date, ABLV surveillance has primarily been passive,
with active surveillance concentrating on eastern and northern Australian bat populations. As a
result, there is scant regional ABLV information for large areas of the country. To better inform the
local public health risks associated with human-bat interactions, this study describes the lyssavirus
prevalence in microbat communities in the South West Botanical Province of Western Australia. We
used targeted real-time PCR assays to detect viral RNA shedding in 839 oral swabs representing
12 species of microbats, which were sampled over two consecutive summers spanning 2016–2018.
Additionally, we tested 649 serum samples via Luminex® assay for reactivity to lyssavirus antigens.
Active lyssavirus infection was not detected in any of the samples. Lyssavirus antibodies were
detected in 19 individuals across six species, with a crude prevalence of 2.9% (95% CI: 1.8–4.5%) over
the two years. In addition, we present the first records of lyssavirus exposure in two Nyctophilus
species, and Falsistrellus mackenziei.
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1. Introduction
Australian bat lyssavirus (ABLV) is one of the 16 classified species of lyssaviruses within the family
Rhabdoviridae [1]. It was first discovered in Australia in 1996 [2] and early studies distinguished two
variants, the pteropid variant carried by all four species of flying fox within continental Australia [3],
and the insectivorous variant detected only in the yellow-bellied sheath-tailed bat (Saccolaimus
flaviventris) [4]. Although there is evidence of ABLV exposure in 11 genera within four microbat
families [5], additional reservoir species have yet to be identified.
Both ABLV strains are associated with clinical disease in the host species [2,4]. Although spillover
events are extremely rare, they have resulted in fatal neurological disease in humans and horses [6–8],
making ABLV an agent of significant public health concern. Current public health policy recommends
a prophylactic rabies vaccination for bat handlers, with the administration of post-exposure treatment
including vaccination and rabies immunoglobulin based on vaccination history and individual immune
status [9]. However, the perceived risk from exposure to microbats is potentially limited by the relative
lack of media exposure these species receive compared to the larger pteropids, coupled with only a
single documented microbat to human transmission of ABLV to date.
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Since the discovery of ABLV, surveillance has predominantly relied on passive sampling regimes,
with a single published study based on active sampling in the east and north of the country [10].
Results suggest ABLV circulates at a low prevalence (<1%) in healthy wild bat populations [5].
However, the prevalence (and therefore risk) escalates to 5%–10% where bats are injured, sick or
orphaned. These are precisely the conditions which are considered to drive human exposure through
rescue and rehabilitation attempts, or the protection of property, pets or children [11–13]. Interestingly,
the public health research on ABLV and human-bat interactions to date does not report on community
knowledge or risk perceptions of microbats versus pteropid species, generally referring to ‘bats’ as a
broad group [11–15]. Therefore, whilst basic knowledge of ABLV in bats appears to be high in some
regions [11], public awareness of the specific risks and recommended post-exposure behaviours with
respect to microbats warrants further research.
In Western Australia, ABLV surveillance has also been sporadic and passive, with the only
targeted study focusing on the far northern part of the state and concentrating mainly on the pteropid
bats in the region [5], with sample collection occurring some 15 years ago. Active surveillance of
microbats has likely been hindered by the additional time and resource demands of sampling non-cave
roosting species typical of the region [16]. Therefore, there is limited current information on the ABLV
status of Western Australian microbat species and the disease status is assumed by the extrapolation
of information from bat populations in the eastern states. Additionally, there is no local data of ABLV
status in the south west of Western Australia, an area with arguably increased human-bat interaction
due to the higher population density.
In order to better inform the regional risks associated with human-bat interactions, this study
aimed to establish the lyssavirus status of insectivorous bats in the South-West Botanical Province of
WA over a period of two years. We used an ABLV specific and a pan-lyssavirus reverse transcription
real-time PCR (RRT-PCR) assay to screen oral swabs from 12 species of microbats. Additionally,
we used a bead-based Luminex® assay on serum samples to determine previous lyssavirus exposure.
2. Materials and Methods
All sampling was approved by the Department of Parks and Wildlife of Western Australia,
permits 08-001359-1, and CE005517. Capture, handling and sampling procedures were approved by
the Murdoch University Animal Ethics Committee (R2882/16).
Harp traps and mist nets were used to capture bats at different locations of the South-West
Botanical Province (SWBP), an Australian global biodiversity hotspot. The province covers
approximately 44 million hectares and comprises nine bioregions [17]. Remnant natural cover in
the east and west of the region is separated by the extensive monoculture known as the Western
Australian wheatbelt, which acts as a major dispersion barrier for many native species.
Sampling took place over two summers between 2016 and 2018, with sites in the east and
west boundaries of the wheatbelt. The northeastern sites were within the semi-arid Avon bioregion
which was predominantly sampled during the first season (2016–2017). The southwestern sites were
distributed across five bioregions, the Esperance Plains, Geraldton Sandplains, Jarrah Forest, Swan
Coastal Plain, and Warren (Figure 1), which were mainly sampled during the second year of the study
(2017–2018). Therefore, most sampling sites were visited only once over the two years, except for
locations in the Avon bioregion which were sampled during both summers.
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Figure 1. The South West Botanical province (SWBP) highlighted in brown. Sampling sites are shown 
and sites where seropositive individuals were identified are labelled I-VII. Presence (light areas) and 
absence (dark areas) of human populations are shown. The SWBP encompasses nine bioregions, Avon 
Wheatbelt (AVW), Coolgardie (COO), Esperance Plains (ESP), Geraldton Sandplains (GES), Hampton 
(HAM), Jarrah Forest (JAF), Mallee (MAL), Swan Coastal Plain (SWA), and Warren (WAR). 
Prior to undertaking trapping, all personnel involved in handling bats underwent a complete 
rabies vaccination schedule. Biosecurity and biosafety protocols during handling and sampling 
included the use of protective gloves while manipulating bats out of traps and nets. During sample 
collection, double gloves were worn while restraining the animal (nitrile gloves over protective 
gloves), with the nitrile gloves changed between each bat. All surfaces and non-disposable equipment 
(e.g. calipers) were disinfected with a 10% solution of F10 (Health and Hygiene, South Africa) 
between each bat. Additionally, single calico bags were used for each individual and soaked in F10 
before being re-used. 
Following capture, bats were taxonomically identified, and a single oral swab (FLOQSwab, 
Copan, Brescia, Italy) was collected per individual and stored in RNAlater® (Ambion, Life 
Technologies, Carlsbad, CA, USA). Additionally, 10 µL of blood was taken from the brachial vein 
and diluted 1:10 in phosphate buffered saline (PBS).  
Oral swabs were vortexed and 50 µL of the supernatant used as starting material for all 
extractions using a Magmax viral RNA extraction kit (Ambion, Applied Biosystems, Vilnius, 
Lithuania) following the manufacturer’s instructions. The detection of lyssavirus RNA was 
performed using an Australian bat lyssavirus RRT-PCR specific for the insectivorous variant of the 
virus [18], and a pan-lyssavirus RRT-PCR assay [19]. Inactivated insectivorous ABLV RNA provided 
by the CSIRO Australian Animal Health Laboratory (AAHL, Victoria, Australia) was used as a 
positive control. Assays were performed on a QuantStudio 6 Flex platform (Life Technologies, 
Singapore). Nucleic acid extraction verification and lack of inhibitors were assessed using an 
endogenous 18S rRNA PCR assay (Life Technologies, Pleasanton, CA, USA).  
Sera were tested for reactivity to lyssavirus antigens [20] in an indirect binding Luminex® assay 
[21], at a final working dilution of 1:50 at CSIRO AAHL. As a pilot study, samples collected during 
the first season were pooled one in three (n = 246) or one in four (n = 24). All samples collected during 
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Sera were tested for reactivity to lyssavirus antigens [20] in an indirect binding Luminex®
assay [21], at a final working dilution of 1:50 at CSIRO AAHL. As a pilot study, samples collected
during the first season were pooled one in three (n = 246) or one in four (n = 24). All samples collected
during the second season were tested individually (n = 391). Median Fluorescence Intensity (MFI)
was read using a Bio-Plex instrument (Bio-Rad Laboratories, Hercules, CA, USA). Due to the lack
of known positive and known negative bat sera from the species captured in this study to validate
the assay, the MFI threshold to differentiate positive and negative samples was set at 1000 MFI as
per CSIRO protocols. Previous studies published by the Australian Animal Health Laboratory and
elsewhere using the same Bio-Plex platform have used a threshold of at least three times the mean
MFI of negative sera from other bat species with values below 250 MFI considered negative [22–25].
The same principle was used here to establish a threshold based on an MFI of 250 corresponding to a
negative sample with sample MFIs above 1000 considered positive.
Prevalence estimates and 95% confidence intervals were calculated using the Wilson’s Method [26]
as implemented in the R package epitools [27].
3. Results
In total, 839 oral swabs and 661 blood samples were collected. Twelve samples did not provide
a valid Luminex® assay result and were removed from the analysis. Therefore, the final serological
dataset comprised 649 samples encompassing 12 bat species (Table 1). Captured species composition
varied at each location (Figure 2) and in general Chalinolobus gouldii and Vespadelus regulus had the
greatest representation in the swab and sera data sets (Table 1). A total of 270 serum samples were
collected in the first year and 379 during the second year.
Table 1. Seroprevalence of Australian Bat Lyssavirus in 12 species of microbats of the South West
Botanical Province of Western Australia. The total number of samples tested and positives () are shown.
Family Species Swabs Sera Seroprevalence 1
Vespertilionidae
Chalinolobus gouldii 287(0) 262(2) 0.7 (0.2–2.7)
Chalinolobus morio 105(0) 64(3) 4.6 (1.6–12.8)
Falsistrellus mackenziei 14(0) 7(1) NC 2
Nyctophilus geoffroyi 69(0) 48(0)
Nyctophilus gouldi 78(0) 66(3) 4.5 (1.5–12.5)
Nyctophilus major 12(0) 5(1) NC 2
Nyctophilus sp 3 6(0) 5(0)
Scotorepens balstoni 13(0) 8(0)
Vespadelus baverstocki 6(0) 5(0)
Vespadelus finlaysoni 1(0) 0
Vespadelus regulus 227(0) 164(9) 5.5 (2.9–10.1)
Vespadelus sp 3 2(0) 1(0)
Molossidae
Austronomus australis 13(0) 11(0)
Ozimops sp 6(0) 3(0)
1 Prevalence (%) and 95% confidence intervals (CI). 2 Prevalence estimates not calculated (NC) due to small sample
size. 3 These individuals were not confidently identified to species level, however will belong to either of the listed
Nyctophilus or Vespadelus species, and therefore do not count towards the total number of species sampled.
Neither the ABLV specific or the pan-lyssavirus RRT-PCR reactions yielded a positive result.
No inhibition was detected in any of the samples and positive and negative controls were valid.
Serological reactivity to lyssavirus antigens was detected in 19 samples (Table 1, Table S1) resulting
in an overall antibody prevalence of 2.9% (95% CI: 1.8–4.5%). Seropositive samples encompassed six
species, V. regulus had the highest prevalence at 5.5% (95% CI: 2.9–10.1%), followed by C. morio (4.6%,
95% CI: 1.6–12.8), Nyctophilus gouldi (4.5%, 95% CI: 1.5–12.5) and C. gouldii (0.7%, 95% CI: 0.2–2.7%).
Additionally, reactivity was also detected in a single Falsistrellus mackenziei, and an N. major. Due to
their small sample sizes, prevalence values were not estimated for these two species (Table 1).
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of the study, and south of the wheatbelt. Consequently, annual seroprevalence significantly increased 
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Seropositive individuals were captured at seven sites which were dominated by natural jarrah 
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that the majority (78%) of captures in the first year and north of the wheatbelt were dominated by a
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Here we report the first comprehensive study investigating the lyssavirus status of apparently
healthy populations of insectivorous bats in the South West Botanical Province of WA. Significantly,
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this is the first active surveillance to take place in the SWBP and therefore constitutes an update to the
existing limited lyssavirus data on wild microbat populations [10]. We did not detect any current ABLV
infection or the presence of any other lyssavirus species circulating within the sampled populations,
despite the large sample size (n = 839). The suitability of oral swabs for lyssavirus detection has
previously been demonstrated in clinical studies [18,28–30], and in active lyssavirus surveillance
efforts [31,32]. Nonetheless, diagnostic sensitivity in a field surveillance setting for the detection
of ABLV may be limited by the combination of intermittent shedding [33], and a small window of
infection [32,34] of an already low prevalence virus.
Serological results indicated previous lyssavirus exposure in 19 individuals, resulting in an overall
seroprevalence of 2.9% in the study population. This result is congruent with previous sero-response
estimates of wild Australian bat populations [5], albeit using a different serological assay. Antibody
reactivity was detected in six Vespertilionidae species, C. gouldii, C. morio, V. regulus, F. mackenziei,
N. gouldi, and N. major. The presence of lyssavirus antibodies has previously been documented for
the Chalinolobus and Vespadelus genera [5], and the results here constitute the first published report
of lyssavirus exposure in Nyctophilus spp. and F. mackenziei, an endemic species of the jarrah forests
of the South West. It was not possible to carry out further confirmatory testing on seropositive
individuals, as the volume of blood ethically permissible to be drawn from microbats was fully used
in the Luminex® assay.
Seroprevalence values per species varied between 0.7% and 5.5%, with the highest values observed
in V. regulus (5.5%), C. morio (4.6%) and N. gouldi (4.5%). Despite the existence of previously published
seroprevalence figures for some Australian Vespertilionidae species [5], it is not appropriate to make
direct comparisons due to previous results grouping different species by genera and being based on an
alternative serological assay. Even though seropositivity for ABLV has previously been reported in
Austronomus australis [5], we did not detect any antibody response in this species, possibly due to the
small sample size (n = 11).
All seropositive individuals originated from seven locations within the Jarrah and Warren
bioregions and none from the Avon bioregion, which is isolated by the Australian wheatbelt. It is
unclear whether this partitioning of the data represents a geographical, temporal or a species
association given these risk factors are confounded in the study population. However, temporal
shedding may explain the 0% prevalence in the Avon bioregion despite the large sample size (n = 226),
as this region was predominantly sampled in the first year and all the seropositive individuals occurred
in the second year of the study. This hypothesis is supported by longitudinal studies elsewhere showing
that inter-annual variation of seroprevalence estimates is common in wild bat populations [28,32].
Further, long term active surveillance in Myotis myotis has provided important insights into the
infection dynamics of lyssavirus at a temporal and geographical scale [32], highlighting how similar
studies would contribute to better understanding of ABLV dynamics within Australian microbat
populations. It is possible that a failure to detect seropositive samples during the first year could also
have been the result of decreased assay sensitivity triggered by sample pooling. However, titration
studies using pools of Pteropus alecto sera by CSIRO AAHL have not demonstrated a loss of assay
sensitivity at the pooling levels used in this study.
The detection of ABLV seropositivity in the SWBP, particularly the southern parts of the region,
further supports the existence of additional lyssavirus reservoirs, as the distribution of Pteropus
spp. and Saccolaimus flaviventris does not extend to the SWBP. This suggests that any hypothetical
reservoir may be a member of the families Vespertilionidae or Molossidae, with serology results
indicating Vespertilionidae may be a reservoir genus in the Southwest of WA. Importantly, seropositive
individuals of six separate species came from a variety of areas in the south west in relatively close
proximity to towns and recreational areas (<20 km).
The results from this study suggest that active infections in wild microbat populations may be
even lower than previously thought. Despite this, the evidence of circulating ABLV in the region
validates current recommendations for post-exposure treatment of people with bat bites and scratches,
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including those from microbats. We recommend public health research akin to that conducted in the
eastern states [11–15] in order to evaluate knowledge, attitudes and perceptions of ABLV risks in the
south west of WA specifically for microbat species. This information should be used to guide future
public health campaigns in the region.
Supplementary Materials: The following are available online at http://www.mdpi.com/2414-6366/4/1/46/s1,
Table S1 Median Fluoresce Intensity values for all sera tested.
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